Cardiac Biomarkers Market by Type (Myocardial muscle Creatine Kinase (CK-MB), Troponins (T and I), Myoglobin, Brain Natriuretic Peptide (BNPs) or NT-proBNP, Ischemia Modified Albumin (IMA), and Others), by Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), by Location of Testing (Point of Care Testing and Laboratory Testing) - Global Opportunity Analysis and Industry Forecast, 2020 – 2030
Industry: Healthcare | Publish Date: 22-Sep-2020 | No of Pages: 296 | No. of Tables: 151 | No. of Figures: 136 | Format: PDF | Report Code : N/A
Market Definition
The global Cardiac Biomarkers Market size was valued at USD 8.42 billion in 2019 and is predicted to reach USD 28.29 billion by 2030, with a CAGR of 11.6% from 2020-2030.
Cardiac biomarkers are protein-based substrates released into the blood stream when the heart is extremely stressed or damaged. Cardiac biomarkers can be traced and measured to diagnose Cardio Vascular Diseases (CVDs) such as Acute Coronary Syndrome (ACS), myocardial infraction, cardiac ischemia, and others.
Cardiac biomarker is an integrated diagnostic approach for prevention of CVDs by monitoring the heart conditions. Due to high sensitivity, it gives rapid results for immediately initiating the diagnostic and treatment procedures.
The adoption of cost-effective Cardiac Point of Care (PoC) testing kits that offer quick results with higher accuracy are gaining momentum over the period, thereby supplementing the growth of cardiac biomarkers market.
Market Dynamics and Trends
According to the data World Health Organization, more than 17.9 million people worldwide, die of Cardiovascular diseases (CVDs), every year. This scenario consequently escalates the demand for advanced healthcare facilities that offer precise diagnostics, monitoring and treatments options for patients suffering from CVDs, thereby propagating the growth of global cardiac biomarkers market.
Furthermore, benefits offered by cardiac biomarkers such as, fast and precise depictions of heart failures after the one-set of chest pain, and high sensitivity of biomarkers test-kit offering precise results; are expected to propagate the growth of global market.
However, limited use of biomarkers test in specific cases, and risk of skeletal injury are the limiting factors expected to slow down the growth of cardiac biomarkers market.
Moreover, multiple options to formulate different combinations for cardiac biomarkers testing, manufacturers offering various customized solutions, and increasing investment in the R&D activities for new clinical research by government and non-government authorities, are the factors anticipated to propel the growth of global market in coming future.
Market Segmentations and Scope of the Study
The global cardiac biomarkers market share has been analyzed based on type, application, location of testing and geography.
Based on product type, the cardiac biomarkers market report is segmented into Myocardial muscle Creatine Kinase (CK-MB), Myoglobin, Brain Natriuretic Peptide (BNPs), Troponins (T and I), or NT-proBNP, Ischemia Modified Albumin (IMA), and Others. Based on application, the market is categorized into Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others. Based on location of testing, the market is divided into Point of care testing and Laboratory testing. Geographic breakdown and analysis of each of the previously mentioned segments include regions comprising North America, Europe, Asia-Pacific, and RoW.
Geographical Analysis
North America dominated the global cardiac biomarkers market, and is expected to maintain this trend throughout the forecast period, accounting for the highest market share. This is attributed to well-established healthcare infrastructures and medical laboratories. Moreover, increasing incidences of CVDs due to sedimentary lifestyles, and adoption of PoC gaining momentum, are the factors expected to further propel the market growth in this region.
Asia Pacific region is expected to grow substantially in the global market, owing to increasing accessibility to healthcare facilities, higher prevalence of CVDs due constantly multiplying population, increasing medical tourism, and increasing awareness regarding treatment options.
Competitive Landscape
The cardiac biomarkers industry is highly competitive and consists of various market players. Some of the major market players include Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, BioMerieux, Beckman Coulter, Randox laboratories, and Thermo Fisher Scientific among others.
An upsurge in R&D activities and new product launches by the key players, is leading the healthcare infrastructure to new heights, thereby creating lucrative opportunities in the global cardiac biomarkers market.
For instance, in September 2019, Abbott, one of the major players in the global market, introduced a test to assist in curing the troponin dilemma. Abbott’s High Sensitivity Troponin-I (hsTnI) blood test measures very low levels of troponin, allowing doctors to assess heart attack in patients within two to four hours of admission. It has achieved a green signal for commercialization in the U.S. to help diagnose heart attacks in men and women.
Key Benefits
-
The cardiac biomarkers market report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on.
-
The study comprises a deep dive analysis of the market trend including the current and future trends for depicting the prevalent investment pockets in the market.
-
The report provides detailed information related to key drivers, restraints, opportunities, and their impact on the global market.
-
The report incorporates competitive analysis of the market players along with their market share in the global market.
-
The SWOT analysis and Porters Five Forces model is elaborated in the study of the market.
-
Value chain analysis in the cardiac biomarkers market study provides a clear picture of the stakeholders’ roles.
Cardiac Biomarkers Market Key Segments
By Type
-
Myocardial muscle Creatine Kinase (CK-MB)
-
Troponins (T and I)
-
Myoglobin
-
Brain Natriuretic Peptide (BNPs) or NT-proBNP
-
Ischemia Modified Albumin (IMA)
-
Others
By Application
-
Myocardial Infarction
-
Congestive Heart Failure
-
Acute Coronary Syndrome
-
Atherosclerosis
-
Others
By Location of Testing
-
Point of care testing
-
Laboratory testing
By Geography
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Rest of Europe
-
-
Asia-Pacific
-
China
-
India
-
Japan
-
Australia
-
Rest of Asia-Pacific
-
-
RoW
-
Latin America
-
Middle East
-
Africa
-
Report Scope and Segmentation
|
Parameters |
Details |
|
Analysis Period |
2019–2030 |
|
Base Year Considered |
2020 |
|
Forecast Period |
2020–2030 |
|
Market Size Estimation |
Billion (USD) |
|
Market Segmentation |
By Type (Creatine Kinase, Troponins, Myoglobin, Natriuretic peptides, Ischemia Modified Albumin, Other Type) By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, Other Application) By Location of Testing (Point of care testing, Laboratory testing) |
|
Geographical Segmentation |
North America (U.S., Canada, Mexico) Europe (UK, Germany, France, Rest of Europe), Asia-Pacific (China, Japan, Australia, India, Rest of APAC), Rest of the World (Latin America, Middle East, Africa) |
|
Companies Profiled |
Roche Diagnostics, Siemens Healthcare, Abbott Laboratories, Alere Inc., Bio-Rad Laboratories, Becton, Dickinson and Company, BioMerieux, Beckman Coulter, Randox laboratories, and Thermo Fisher Scientific. |
KEY PLAYERS:
-
Roche Diagnostics
-
Siemens Healthcare
-
Abbott Laboratories
-
Alere Inc.
-
Bio-Rad Laboratories
-
Becton, Dickinson and Company
-
BioMerieux
-
Beckman Coulter
-
Randox laboratories
-
Thermo Fisher Scientific
At Next Move Strategy Consulting, we understand that insightful market research is the cornerstone of successful business decisions. That's why we employ a robust and multifaceted approach, combining various methodologies to deliver the most accurate and actionable data for our clients.
Research Landscape
We navigate the world of research with two primary approaches:
Qualitative Approach
Our qualitative research methodologies involve immersive techniques such as in-depth interviews, focus groups, and observational studies. By engaging directly with individuals and stakeholders, we uncover valuable insights that quantitative data alone may overlook.
Quantitative Research
In tandem with qualitative methodologies, NMSC leverages the power of Quantitative Research to provide a robust foundation of numerical insights. Through systematic data collection and analysis, we quantify patterns, preferences, and market trends, offering a comprehensive view of the business landscape.
Our quantitative research approach employs diverse tools, including surveys, experiments, and statistical modelling. These methodologies enable us to gather data from a large and representative sample, ensuring the statistical significance of our findings. By employing structured questionnaires and standardized data collection methods, we guarantee the reliability and validity of the information we present to our clients.
Quantitative research is particularly effective in measuring the prevalence of trends, assessing market size, and gauging the impact of various factors on consumer behavior. The numerical precision attained through this approach equips our clients with actionable insights, facilitating data-driven decision-making and strategy formulation.
Our Specialized Toolbox for Industry-Specific Market Research
We deploy a specialized arsenal of techniques tailored to meet your unique requirements. Here's a glimpse into our comprehensive toolbox:
Information Procurement
The stage entails acquiring market data or relevant information through various sources and methodologies.
Market Research Approach
We utilize both top-down and bottom-up approaches in market research analysis to achieve a comprehensive understanding of the market dynamics, leveraging the broad perspective of industry trends and macroeconomic factors alongside detailed insights from specific segments and individual companies.
Porters Five Forces Analysis
We conduct Porter's Five Forces analysis to evaluate the competitive landscape of an industry, providing us with insights into factors that affect profitability and strategic positioning.
SWOT Analysis
We conduct SWOT analysis to understand market trends, identify potential threats, capitalize on opportunities, and assess our strengths and weaknesses.
Forecasting
We utilize a forecasting model to predict future consumption by considering parameters like population, economics, regulations, market competition, drivers, constraints, technology, and pricing. We also employ statistical techniques such as multilinear regression, exponential smoothing, moving average, ARIMA, and Monte Carlo simulations for accurate predictions. In econometric forecasting, we analyzed short-term and long-term event impacts, attributing values based on regulatory frameworks, economic factors, and market events.
Frequently Asked Questions
Download Free Sample
Speak to Our Analyst
Related Report
Related Blogs
Role Of Companies In Shaping The Blood Gas And Electrolyte Analyzer Market
According to Next Move Strategy Consulting, the global blood...
Analysis of Key Players Operating in the Global Surgical Instrument Industry
Next Move Strategy Consulting forecasts more than 1.7-fold g...
CBCT Industry Is Dominated By Dentsply Sirona, Philips, & Vatech With More Than 45% – Know Why
Next Move Strategy Consulting predicts a significant growth...
